ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy Study of Pain Shield Device to Treat Subjects Following Laparoscopic-Assisted Abdominal Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00737425
Recruitment Status : Unknown
Verified October 2008 by Shaare Zedek Medical Center.
Recruitment status was:  Recruiting
First Posted : August 19, 2008
Last Update Posted : October 28, 2008
Sponsor:
Collaborator:
Nanovibronix
Information provided by:
Shaare Zedek Medical Center

Brief Summary:
The purpose of this study is to evaluate safety and efficacy of PainShield device, based on ultrasound technology, for postoperative pain relief and wound healing following a laparoscopic-assisted abdominal surgery.

Condition or disease Intervention/treatment Phase
Wounds Device: PainShield Device: Sham PainShield Phase 4

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Evaluation of Safety and Efficacy of the PainShield Device for the Treatment of Subjects Who Underwent Laparoscopic-Assisted Abdominal Surgery
Study Start Date : September 2008

Arm Intervention/treatment
Active Comparator: 1 Device: PainShield
Sham Comparator: 2 Device: Sham PainShield



Primary Outcome Measures :
  1. Pain and discomfort will be measured using appropriate validated questionnaires. [ Time Frame: Pain assessment will be performed daily ]

Secondary Outcome Measures :
  1. Infections will be assessed by concomitant antibiotic intake [ Time Frame: Concomitant medications will be assessed daily ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subject's Age ≥ 18
  • Subject is able, agrees and signs the Informed Consent Form
  • Subject requires laparoscopic-assisted abdominal surgery
  • Incision size following the laparoscopy between 4-7 cm

Exclusion Criteria:

  • Epidural analgesia
  • IV PCA
  • Subject has any condition, which precludes compliance with study and/or device instructions
  • Subject is currently participating in another clinical study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00737425


Contacts
Contact: Petachia Reissman, MD +972 2 6666310
Contact: Eran Lavi, MD +972 2 6666310

Locations
Israel
Shaare Zedek Medical Center Recruiting
Jerusalem, Israel
Sponsors and Collaborators
Shaare Zedek Medical Center
Nanovibronix

Responsible Party: Prof Petachia Reissman, Head of Surgery Department, Shaare Zedek Medical Center, Jerusalem, Israel
ClinicalTrials.gov Identifier: NCT00737425     History of Changes
Other Study ID Numbers: NV-PS-02-001
First Posted: August 19, 2008    Key Record Dates
Last Update Posted: October 28, 2008
Last Verified: October 2008

Keywords provided by Shaare Zedek Medical Center:
laparoscopic-assisted surgery
abdominal
pain relief
wound healing
low intensity ultrasound